Microalbuminuria in hypertensive nondiabetic patients with ST elevation myocardial infarction

Journal of Cardiovascular Medicine

Volumn 11, Issue 10, 2010, Pages 748-753

  Lazzeri, Chiara ^a   Valente, Serafina ^a   Chiostri, Marco ^a   Picariello, Claudio ^a   Gensini, Gian F ^a  

^a CAREGGI UNIVERSITY HOSPITAL   (Italy)

Author keywords

Hyperglycemia; hypertension; insulin resistance; microalbuminuria; nondiabetic; percutaneous coronary intervention; STEMI

Indexed keywords

CREATINE KINASE; CREATINE KINASE MB; GLUCOSE; TROPONIN I;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HEART ARRHYTHMIA; HEART INFARCTION SIZE; HUMAN; HYPERTENSION; INSULIN RESISTANCE; LUNG EDEMA; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; MORTALITY; PREVALENCE; PROGNOSIS; REVASCULARIZATION; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION;

AGED; AGED, 80 AND OVER; ALBUMINURIA; ANGIOPLASTY, BALLOON, CORONARY; ARRHYTHMIAS, CARDIAC; BLOOD GLUCOSE; CHI-SQUARE DISTRIBUTION; FEMALE; HOSPITAL MORTALITY; HUMANS; HYPERGLYCEMIA; HYPERTENSION; INCIDENCE; INSULIN RESISTANCE; ITALY; LOGISTIC MODELS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PULMONARY EDEMA; RISK ASSESSMENT; RISK FACTORS; TREATMENT OUTCOME;

EID: 77956268181     PISSN: 15582027     EISSN: None     Source Type: Journal    
DOI: 10.2459/JCM.0b013e32833acd00     Document Type: Article

References (28)

1. Stehouwer CD, Smulders YM. Microalbuminuria and risk for cardiovascular disease: analysis of potential mechanisms. J Am Soc Nephrol 2006; 17:2106-2111.
2. Sierra C, de la Sierra A. Early detection and management of the high-risk patient with elevated blood pressure. Vasc Health Risk Manag 2008; 4:289-296.
3. Gosling P, Czyz J, Nightingale P, Manji M. Microalbuminuria in the intensive care unit: clinical correlates and association with outcomes in 431 patients. Crit Care Med 2006; 34:2158-2166.
4. Abid O, Sun Q, Sugimoto K, Mercan D, Vincent JL. Predictive value of microalbuminuria in medical ICU patients: results of a pilot study. Chest 2001; 120:1984-1988.
5. Gopal S, Carr B, Nelson P. Does microalbuminuria predict illness severity in critically ill patients on the intensive care unit?: a systematic review. Crit Care Med 2006; 34:1805-1810.
6. Berton G, Citro T, Palmieri R, Petucco S, De Toni R, Palatini P. Albumin excretion rate increases during acute myocardial infarction and strongly predicts early mortality. Circulation 1997; 96:3338-3345.
7. Taskiran M, Feldt-Rasmussen B, Jensen GB, Jensen JS. Urinary albumin excretion in hospitalized patients with acute myocardial infarction: prevalence of microalbuminuria and correlation to left ventricle wall thickness. Scand Cardiovasc J 1998; 32:163-166.
8. Gosling P, Hughes EA, Reynolds TM, Fox JP. Microalbuminuria is an early response following acute myocardial infarction. Eur Heart J 1991; 12:508-513.
9. Lekatsas I, Koulouris S, Triantafyllou K, Chrisanthopoulou G, Moutsatsou-Ladikou P, Ioannidis G, et al. Prognostic significance of microalbuminuria in nondiabetic patients with acute myocardial infarction. Int J Cardiol 2006; 106:218-223.
10. Berton G, Cordiano R, Mbaso S, De Toni R, Mormino P, Palatini P. Prognostic significance of hypertension and albuminuria for early mortality after acute myocardial infarction. J Hypertens 1998; 16:525-530.
11. Buiatti E, Barchielli A, Marchionni N, Balzi D, Carrabba N, Valente S, et al. Determinants of treatment strategies and survival in acute myocardial infarction: a population-based study in the Florence district, Italy: results of the acute myocardial infarction Florence registry (AMI-Florence). Eur Heart J 2003; 24:1195-1203.
12. Boden WE, O'Rourke RA, Teo KK, Hartigan PM, Maron DJ, Kostuk WJ, et al., COURAGE. Trial Research Group. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med 2007; 356:1503-1516.
13. Alpert JS, Thygesen K, Jaffe A, White HD. The universal definition of myocardial infarction: a consensus document: ischaemic heart disease. Heart 2008; 94:1335-1341.
14. Thygesen K, Alpert JS, White HD, Joint ESC/ACCF/AHA/WHF task force for the redefinition of myocardial infarction. Universal definition of myocardial infarction. Eur Heart J 2007; 28:2525-2538.
15. Valente S, Lazzeri C, Chiostri M, Giglioli C, Sori A, Tigli S, Gensini GF. NT-proBNP on admission for early risk stratification in STEMI patients submitted to PCI: relation with extension of STEMI and inflammatory markers. Int J Cardiol 2009; 132:84-89.
16. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009; 150:604-612.
17. Balkau B, Charles M, for the European Group for the study of insulin resistance (EGIR). Comment on the provisional report from the WHO consultation. Diabet Med 1999; 16:442-443.
18. Berglund G, Elmsta?hl S, Janzon L, Larsson SA. The Malmö Diet and Cancer Study: design and feasibility. J Intern Med 1993; 233:45-51.
19. Lazzeri C, Sori A, Chiostri M, Gensini GF, Valente S. Prognostic role of insulin resistance as assessed by homeostatic model assessment index in the acute phase of myocardial infarction in nondiabetic patients submitted to percutaneous coronary intervention. Eur J Anesthesiol 2009; 26:856-862.
20. Silber S, Albertsson P, Aviles FF, Camici PG, Colombo A, Hamm C, et al. Guidelines for percutaneous coronary interventions: the task force for percutaneous coronary interventions of the European Society of Cardiology. Eur Heart J 2005; 26:804-847.
21. Mykkänen L, Zaccaro DJ, Wagenknecht LE, Robbins DC, Gabriel M, Haffner SM. Microalbuminuria is associated with insulin resistance in nondiabetic subjects: the insulin resistance atherosclerosis study. Diabetes 1998; 47:793-800.
22. Kuusisto J, Mykkä nen L, Pyö rä lä K, Laakso M. Hyperinsulinemic microalbuminuria: a new risk indicator for coronary heart disease. Circulation 1995; 91:831-837.
23. Valente S, Lazzeri C, Vecchio S, Giglioli C, Margheri M, Bernardo P, et al. Predictors of in-hospital mortality after percutaneous coronary intervention for cardiogenic shock. Int J Cardiol 2007; 114:176-182.
24. Lazzeri C, Chiostri M, Sori A, Valente S, Gensini GF. Post procedural hyperglycemia in ST elevation myocardial infarction submitted to percutaneous coronary intervention: a prognostic indicator and a marker of metabolic derangement. J Cardiovasc Med 2010; 11:7-13.
25. Gilardini L, Zulina A, Girola A, Redaelli C, Conti A, Invitti C. Predictors of the early impairment of renal disease in human obesity. Int J Obes 2010; 34:287-294.
26. Klausen K, Borch-Johnsen K, Feldt-Rasmussen B, Jensen G, Clausen P, Scharling H, et al. Very low levels of microalbuminuria are associated with increased risk of coronary heart disease and death independently of renal function, hypertension and diabetes. Circulation 2004; 110:32-35.
27. Gerstein HC, Mann JFE, Qilong Y, Zinman B, Dinneen SF, Hoogwerf B, et al. Albuminuria and risk of cardiovascular events, death and heart failure in diabetic and nondiabetic individuals. JAMA 2001; 286:421-426.
28. Borch-Johnsen K, Feldt-Rasmussen B, Strandgaard S, Schroll M, Jensen JS. Urinary albumin excretion: an independent predictor of ischemic heart disease. Arterioscler Thromb Vasc Biol 1999; 19:1992-1997.